Almirall signs deal for Iktos’ AI technology in drug design
Spanish pharmaceutical firm Almirall has agreed with Iktos to leverage the latter’s generative modelling artificial intelligence (AI) technology to design…
Latest Design
-
10 months
-
11 months
-
1 year
-
1 year
-
10 months
-
11 months
-
1 year
-
1 year
Exscientia Q&A: leveraging AI to create bispecific small molecule drugs
UK-based Exscientia uses artificial intelligence (AI) to automate and speed up drug discovery and design. One of the company’s focuses…
Latest News
View More
Almirall signs deal for Iktos’ AI technology in drug design
Spanish pharmaceutical firm Almirall has agreed with Iktos to leverage the latter’s generative modelling artificial intelligence (AI) technology to design novel drugs. Almirall will use…
USPTO reverses decision regarding interfering CRISPR patents
The Patient Trial and Appeal Board (PTAB) of the US Patent and Trademark Office (USPTO) has changed its stance regarding an interference between ten patent…
Company A-Z
View More
Latest Content
View MoreRNA Library
The recent substantial progress in RNA biology underscores the importance of RNA in normal and aberrant cellular functions. RNA is…
Plated Screening Libraries
Having the world’s largest compound collection we keep producing over 150 000 new screening compounds and over 25 000 new…
Hit Locator Library
We created a Hit Locator Library (HLL) that most closely represents the diversity of 2.8 M structures available from stock…
Coronavirus Library
Enamine's Coronavirus Library is designed for the discovery of new SARS-CoV-2 and pan-Coronavirus antivirals, containing 16,800 compounds. To meet the…